The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society Consensus Statement on Diabetic Ketoacidosis in Children and Adolescents
Abstract
Diabetic ketoacidosis (DKA) is the leading cause of morbidity and mortality in children with type 1 diabetes mellitus (TIDM). Mortality is predominantly related to the occurrence of cerebral edema; only a minority of deaths in DKA are attributed to other causes. Cerebral edema occurs in ∼0.3% to 1% of all episodes of DKA, and its etiology, pathophysiology, and ideal method of treatment are poorly understood. There is debate as to whether physicians treating DKA can prevent or predict the occurrence of cerebral edema and the appropriate site(s) for children with DKA to be managed. There is agreement that prevention of DKA and reduction of its incidence should be a goal in managing children with diabetes.To explore these issues, the Lawson Wilkins Pediatric Endocrine Society (LWPES) and the European Society for Pediatric Endocrinology (ESPE) convened a panel‖ of expert physicians for a consensus conference. The meeting was chaired by Mark A. Sperling, MD, representing LWPES, and David B. Dunger, MD, representing ESPE. The Consensus statement was developed with close partnership between the ESPE and LWPES and the International Society for Pediatric and Adolescent Diabetes, all 3 organizations being represented by members who participated in the writing process. The statement also was endorsed by related organizations; the Juvenile Diabetes Research Foundation International, the World Federation of Pediatric Intensive and Critical Care Societies, the European Society for Pediatric Critical Care, the European Society of Pediatric and Neonatal Intensive Care, and the Australian Pediatric Endocrine Group were represented by invited participants.Each of the major topics had a presenter and recorder, responsible for review of the literature and providing evidence-based recommendations according to criteria used by the American Diabetes Association (see Appendix; levels of evidence are indicated in capital letters, in parentheses).1 Type 2 diabetes was not considered. All participants contributed significantly to the development of consensus.This document summarizes the final consensus reached and represents the current “state of the art.”DKA is caused by a decrease in effective circulating insulin associated with elevations in counterregulatory hormones including glucagon, catecholamines, cortisol, and growth hormone. This leads to increased glucose production by the liver and kidney and impaired peripheral glucose utilization, with resultant hyperglycemia and hyperosmolality. Increased lipolysis, with ketone body (β-hydroxybutyrate [β-OHB] and acetoacetate) production causes ketonemia and metabolic acidosis. Hyperglycemia and acidosis result in osmotic diuresis, dehydration, and obligate loss of electrolytes. The biochemical criteria for the diagnosis of DKA include hyperglycemia (blood glucose: >11 mmol/L [∼200 mg/dL]) with a venous pH <7.3 and/or bicarbonate <15 mmol/L. There is associated glycosuria, ketonuria, and ketonemia. Rarely, young or partially treated children as well as pregnant adolescents may present with near-normal glucose values (“euglycemic ketoacidosis”).2DKA is generally categorized by the severity of the acidosis, varying from mild (venous pH: <7.30; bicarbonate concentration: <15 mmol/L) to moderate (pH: <7.2; bicarbonate: <10) to severe (pH: <7.1; bicarbonate: <5).3,4There is wide geographic variation in the frequency of DKA at diabetes onset, and rates correlate inversely with regional incidence of TIDM. Reported frequencies range between 15% and 67% in Europe and North America and may be more common in developing countries (A).5,6 In Canada and Europe, hospitalization rates for DKA in established and new patients with TIDM have remained stable at ∼10 per 100 000 children over the past 20 years, but severity may be decreasing (B).7,8DKA at onset of TIDM is more common in younger children (<4 years of age), children without a first-degree relative with TIDM, and those from families of lower socioeconomic status (A).4,9 High-dose glucocorticoids, atypical antipsychotics, diazoxide, and some immunosuppressive drugs have been reported to precipitate DKA in individuals not diagnosed previously with TIDM (B).10,11The risk of DKA in established TIDM is 1% to 10% per patient per year (A).12–15 Risk is increased in children with poor metabolic control or previous episodes of DKA, peripubertal and adolescent girls, children with psychiatric disorders (including those with eating disorders), and those with difficult family circumstances (including lower socioeconomic status and lack of appropriate health insurance).16 Inappropriate interruption of insulin-pump therapy also leads to DKA.12,14Children whose insulin is administered by a responsible adult rarely have episodes of DKA (C),17 and 75% of episodes of DKA beyond diagnosis probably are associated with insulin omission or treatment error.17,18 The remainder are due to inadequate insulin therapy during intercurrent illness (B).18–20Reported mortal
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke
Manley, G. T., Fujimura, M., Ma, T., Noshita, N., Filiz, F., Bollen, A. W., Chan, P., & Verkman, A. S. (2000) · Nature Medicine · doi:10.1038/72256 · Cited by 1,507
Effects of insulin in relatives of patients with type 1 diabetes mellitus
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012350 · Cited by 836
Inflammatory Mediators and Modulation of Blood–Brain Barrier Permeability
Abbott, N. J. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007074420772 · Cited by 803
Risk Factors for Cerebral Edema in Children with Diabetic Ketoacidosis
Glaser, N., Barnett, P., McCaslin, I., Nelson, D., Trainor, J., Louie, J., Kaufman, F., Quayle, K., Roback, M., Malley, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101253440404 · Cited by 779
Self-citationRisk Factors for Cerebral Edema in Children with Diabetic Ketoacidosis
(2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442014 · Cited by 533
Morris, A. D., Boyle, D. I., McMahon, A. D., Greene, S. A., MacDonald, T. M., & Newton, R. W. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06234-x · Cited by 507
Grey, M., Boland, E. A., Davidson, M., Li, J., & Tamborlane, W. V. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.106568 · Cited by 503
Predictors of Acute Complications in Children With Type 1 Diabetes
Rewers, A. (2002) · JAMA · doi:10.1001/jama.287.19.2511 · Cited by 496
Regulation of Cell Volume in Health and Disease
McManus, M. L., Churchwell, K. B., & Strange, K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331906 · Cited by 441
Atchley, D. W., Loeb, R. F., Richards, D. W., Benedict, E. M., & Driscoll, M. E. (1933) · Journal of Clinical Investigation · doi:10.1172/jci100504 · Cited by 396
Causes of death in children with insulin dependent diabetes 1990-96
Edge, J. A., Ford-Adams, M. E., & Dunger, D. B. (1999) · Archives of Disease in Childhood · doi:10.1136/adc.81.4.318 · Cited by 384
Self-citationThe risk and outcome of cerebral oedema developing during diabetic ketoacidosis
Edge, J. A., Hawkins, M. M., Winter, D. L., & Dunger, D. B. (2001) · Archives of Disease in Childhood · doi:10.1136/adc.85.1.16 · Cited by 368
Self-citationYang, G. Y., & Betz, A. L. (1994) · Stroke · doi:10.1161/01.str.25.8.1658 · Cited by 333
Vanelli, M., Chiari, G., Ghizzoni, L., Costi, G., Giacalone, T., & Chiarelli, F. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.7 · Cited by 322
Intracerebral Crises During Treatment of Diabetic Ketoacidosis
Rosenbloom, A. L. (1990) · Diabetes Care · doi:10.2337/diacare.13.1.22 · Cited by 318
Subclinical Brain Swelling in Children during Treatment of Diabetic Ketoacidosis
Krane, E. J., Rockoff, M. A., Wallman, J. K., & Wolfsdorf, J. I. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505023121803 · Cited by 272
Self-citationLévy-Marchal, C., Patterson, C. C., Green, A., & on behalf of the EURODIAB ACE Study Group (2001) · Diabetologia · doi:10.1007/pl00002958 · Cited by 254
A Randomized Study of Phosphate Therapy in the Treatment of Diabetic Ketoacidosis*
FISHER, J. N., & KITABCHI, A. E. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-1-177 · Cited by 244
Rosilio, M., Cotton, J.-B., Wieliczko, M.-C., Gendrault, B., Carel, J.-C., Couvaras, O., Ser, N., Gillet, P., Soskin, S., Garandeau, P., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1146 · Cited by 224
New-Onset Diabetes Mellitus and Diabetic Ketoacidosis Associated With Olanzapine Treatment
Goldstein, L. E., Sporn, J., Brown, S., Kim, H., Finkelstein, J., Gaffey, G. K., Sachs, G., & Stern, T. A. (1999) · Psychosomatics · doi:10.1016/s0033-3182(99)71210-7 · Cited by 220
Waldhäusl, W., Kleinberger, G., Korn, A., Dudczak, R., Bratusch-Marrain, P., & Nowotny, P. (1979) · Diabetes · doi:10.2337/diab.28.6.577 · Cited by 201
Komulainen, J., Kulmala, P., Savola, K., Lounamaa, R., Ilonen, J., Reijonen, H., Knip, M., & Akerblom, H. K. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.1950 · Cited by 201
Harris, G. D., Flordalisi, I., Harris, W. L., Mosovich, L. L., & Finberg, L. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82439-4 · Cited by 199
Presentation and progress of childhood diabetes mellitus: a prospective population-based study
Pinkney, J. H., Bingley, P. J., Sawtell, P. A., Dunger, D. B., Gale, E. A. M., & The Bart's-Oxford Study Group (1994) · Diabetologia · doi:10.1007/bf00428780 · Cited by 189
Self-citationDeterminants of Plasma Potassium Levels in Diabetic Ketoacidosis
ADROGUÉ, H. J., LEDERER, E. D., SUKI, W. N., & EKNOYAN, G. (1986) · Medicine · doi:10.1097/00005792-198605000-00004 · Cited by 183
CLINICAL SIGNS OF DEHYDRATION IN CHILDREN
Mackenzie, A., Barnes, G., & Shann, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90723-x · Cited by 178
Kimelberg, H. K., Rutledge, E., Goderie, S., & Charniga, C. (1995) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1995.51 · Cited by 161
Recent Trends in Hospitalization for Diabetic Ketoacidosis in Ontario Children
Curtis, J. R., To, T., Muirhead, S., Cummings, E., & Daneman, D. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1591 · Cited by 160
Self-citationPhosphate Therapy in Diabetic Ketoacidosis
Wilson, H. K., Keuer, S. P., Lea, A. S., Boyd, A. E., & Eknoyan, G. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.142.3.517 · Cited by 157
Cranial CT in children and adolescents with diabetic ketoacidosis.
Hoffman, W. H., Steinhart, C. M., Gammal, T. E., et al. (1988) · PubMed · Cited by 152
Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis.
Hale, P. J., Crase, J., & Nattrass, M. (1984) · BMJ · doi:10.1136/bmj.289.6451.1035 · Cited by 145
Marcin, J. P., Glaser, N. S., Barnett, P., McCaslin, I., Nelson, D., Trainor, J. L., Louie, J. P., KAUFMAN, F. R., Quayle, K. S., Roback, M. G., et al. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.128888 · Cited by 143
Self-citationKomulainen, J., Lounamaa, R., Knip, M., Kaprio, E., & Akerblom, H. (1996) · Archives of Disease in Childhood · doi:10.1136/adc.75.5.410 · Cited by 142
Failure of Adjunctive Bicarbonate to Improve Outcome in Severe Pediatric Diabetic Ketoacidosis
Green, S. M., Rothrock, S. G., Ho, J. D., Gallant, R. D., Borger, R., Thomas, T. L., & Zimmerman, G. J. (1998) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(98)70279-3 · Cited by 141
Ketoacidosis occurring in newly diagnosed and established diabetic children
Smith, C., Firth, D., Bennett, S., Howard, C., & Chisholm, P. (1998) · Acta paediatrica · doi:10.1111/j.1651-2227.1998.tb01499.x · Cited by 137
Cerebral oedema in diabetic ketoacidosis in children
Bello, F., & Sotos, J. F. (1990) · The Lancet · doi:10.1016/0140-6736(90)91587-z · Cited by 131
Dose Response to Insulin in Man: Differential Effects on Glucose and Ketone Body Regulation
Schade, D. S., & Eaton, R. P. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-44-6-1038 · Cited by 125
2,3-DIPHOSPHOGLYCERATE AND TISSUE OXYGENATION IN UNCONTROLLED DIABETES MELLITUS
Alberti, K. G. M. M., Emerson, P. M., Darley, J. H., & Hockaday, T. D. R. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91793-x · Cited by 125
Cerebral hypoxia from bicarbonate infusion in diabetic acidosis
Bureau, M. A., Begin, R. O., Berthiaume, Y., Shapcott, D. J., Khoury, K., & Gagnon, N. (1980) · The Journal of Pediatrics · doi:10.1016/s0022-3476(80)80619-6 · Cited by 124
Phosphate therapy in diabetic ketoacidosis.
Wilson, H. K., Keuer, S. P., Lea, A. S., BOYD, A. E., & Eknoyan, G. (1982) · PubMed · Cited by 122
Danowski, T. S., Peters, J. H., Rathbun, J. C., Quashnock, J. M., & GREENMAN, L. (1949) · Journal of Clinical Investigation · doi:10.1172/jci102037 · Cited by 121
Metabolic Effects of Low-Dose Insulin Therapy on Glucose Metabolism in Diabetic Ketoacidosis
Luzi, L., Barrett, E. J., Groop, L., Ferrannini, E., & DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.11.1470 · Cited by 120
Diabetic ketoacidosis: Role of the kidney in the acid-base homeostasis re-evaluated
Adrogué, H. J., Eknoyan, G., & Suki, W. K. (1984) · Kidney International · doi:10.1038/ki.1984.62 · Cited by 117
The Cerebrospinal Fluid in Diabetic Ketoacidosis
Ohman, J. L., Marliss, E. B., Aoki, T. T., Munichoodappa, C. S., Khanna, V. V., & Kozak, G. P. (1971) · New England Journal of Medicine · doi:10.1056/nejm197102112840601 · Cited by 116
Winter, R. J., Harris, C., Phillips, L. S., & Green, O. C. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90751-4 · Cited by 114
Keller, U. B., & Berger, W. (1980) · Diabetes · doi:10.2337/diab.29.2.87 · Cited by 114
O’Donnell, M. E., Martinez, A., & Sun, D. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.269.6.c1513 · Cited by 108
Metabolic Effects of Sodium Bicarbonate in Management of Diabetic Ketoacidosis
Assal, J.-P., Aoki, T. T., Manzano, F. M., & Kozak, G. P. (1974) · Diabetes · doi:10.2337/diab.23.5.405 · Cited by 107
INCREASED CEREBROSPINAL-FLUID PRESSURE DURING TREATMENT OF DIABETIC KETOSIS
Clements, R. S., Morrison, A. D., Blumenthal, S. A., & Winegrad, A. (1971) · The Lancet · doi:10.1016/s0140-6736(71)92245-8 · Cited by 106
QUINTANA, E. (2004) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(04)00226-4 · Cited by 105
Salutary Effects of Modest Fluid Replacement in the Treatment of Adults With Diabetic Ketoacidosis
Adrogué, H. J. (1989) · JAMA · doi:10.1001/jama.1989.03430150076029 · Cited by 103
International Society for Pediatric and Adolescent Diabetes
Brain, C. E., Hubbard, M., Preece, M. A., Savage, M. O., Aynsley-Green, A., Bouchot, O., Soret, J. Y., Jacqmin, D., Lahlou, N., Roger, M., et al. (1998) · Hormone Research in Paediatrics · doi:10.1159/000023246 · Cited by 103
Self-citationRenal Function and Effects of Partial Rehydration During Diabetic Ketoacidosis
Owen, O. E., Licht, J. H., & SAPIR, D. G. (1981) · Diabetes · doi:10.2337/diab.30.6.510 · Cited by 102
An approach to prevention of recurrent diabetic ketoacidosis in the pediatric population
Golden, M. P., Herrold, A. J., & Orr, D. P. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80124-4 · Cited by 98
Pm, H., Rezvani, I., Braunstein, A. L., Th, L., Martinez, N., & GARIBALDI, L. R. (1997) · Acta Paediatrica · doi:10.1111/j.1651-2227.1997.tb08946.x · Cited by 95
Clinical and Laboratory Features of Type 1 Diabetic Children at the Time of Diagnosis
Lévy‐Marchal, C., Papoz, L., de Beaufort, C. E., Doutreix, J., Froment, V., Voirin, J., & Czernichow, P. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01777.x · Cited by 93
Improving Management of Diabetic Ketoacidosis in Children
Felner, E. I., & White, P. C. (2001) · PEDIATRICS · doi:10.1542/peds.108.3.735 · Cited by 87
Social Factors Associated With Prolonged Hospitalization Among Diabetic Children
Keenan, H. T., Foster, C. M., & Bratton, S. L. (2002) · PEDIATRICS · doi:10.1542/peds.109.1.40 · Cited by 87
Diabetic ketoacidosis with intracerebral complications
Roberts, M. D., Slover, R. H., & Chase, H. P. (2001) · Pediatric Diabetes · doi:10.1034/j.1399-5448.2001.002003109.x · Cited by 83
COMPARATIVE STUDY OF DIFFERENT INSULIN REGIMENS IN MANAGEMENT OF DIABETIC KETOACIDOSIS
Soler, N. G., Wright, A. D., Fitzgerald, M. G., & Malins, J. M. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92068-1 · Cited by 78
Soler, N. G., Dixon, K., Bennett, M., Fitzgerald, M. G., & Malins, J. M. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92083-1 · Cited by 76
Readmissions of Children With Diabetes Mellitus to a Children's Hospital
Glasgow, A. M., Weissberg-Benchell, J. A., Tynan, W. D., Epstein, S., Driscoll, C. A. H., Turek, J., & Beliveau, E. (1991) · PEDIATRICS · doi:10.1542/peds.88.1.98 · Cited by 73
Rate and prediction of infection in children with diabetic ketoacidosis
Flood, R. G., & Chiang, V. W. (2001) · The American Journal of Emergency Medicine · doi:10.1053/ajem.2001.24473 · Cited by 72
Franklin, B. H., Liu, J., & Ginsberg‐Fellner, F. (1982) · PEDIATRICS · doi:10.1542/peds.69.1.87 · Cited by 63
Mechanism of Normochloremic and Hyperchloremic Acidosis in Diabetic Ketoacidosis
Oh, M. S., Carroll, H. J., & Uribarri, J. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000185800 · Cited by 63
Gibby, O. M., Veale, K. E. A., Hayes, T. M., Jones, J. G., & Wardrop, C. A. (1978) · Diabetologia · doi:10.1007/bf01219647 · Cited by 61
Low‐dose insulin therapy in diabetic ketoacidosis: Fact or fiction?
Kitabchi, A. E. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050403 · Cited by 60
Devastating Cerebral Edema in Diabetic Ketoacidosis Before Therapy
Glasgow, A. M. (1991) · Diabetes Care · doi:10.2337/diacare.14.1.77 · Cited by 53
Rhabdomyolysis in diabetic ketoacidosis
Casteels, K., Beckers, D., Wouters, C. H., & Geet, C. V. (2003) · Pediatric Diabetes · doi:10.1034/j.1399-5448.2003.00026.x · Cited by 51
Diabetic Ketoacidosis in Children and the Role of Outpatient Management
Chase, H. P., Garg, S. K., & Jelley, D. H. (1990) · Pediatrics in Review · doi:10.1542/pir.11-10-297 · Cited by 43
The use of an insulin bolus in low-dose insulin infusion for pediatric diabetic ketoacidosis
LINDSAY, R., & Bolte, R. G. (1989) · Pediatric Emergency Care · doi:10.1097/00006565-198906000-00001 · Cited by 43
Acute cerebral dysfunction in diabetic ketoacidosis: Survival followed by panhypopituitarism
Lufkin, E. G., Reagan, T. J., Doan, D. H., et al. (1977) · Metabolism · doi:10.1016/0026-0495(77)90103-2 · Cited by 42
Cerebral Edema in Diabetic Ketoacidosis: A Look Beyond Rehydration
MUIR, A. B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.509 · Cited by 36
Plasma free insulin concentrations: Keystone toeffective management of diabetes mellitus in children
Malone, J. I., & Root, A. W. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80007-8 · Cited by 34
Spontaneous intracerebral hematomas in juvenile diabetic ketoacidosis
Atluru, V. L. (1986) · Pediatric Neurology · doi:10.1016/0887-8994(86)90011-1 · Cited by 31
Simultaneous Acute Cerebral and Pulmonary Edema Complicating Diabetic Ketoacidosis
Young, M. (1995) · Diabetes Care · doi:10.2337/diacare.18.9.1288 · Cited by 30
TREATMENT OF DIABETIC KETOACIDOSIS
Levine, S. N., & Loewenstein, J. E. (1981) · Inpharma Weekly · doi:10.1007/bf03312830 · Cited by 26
Laboratory presentation in diabetic ketoacidosis and duration of therapy
Linares, M. Y. ‐., Schunk, J. E., & LINDSAY, R. (1996) · Pediatric Emergency Care · doi:10.1097/00006565-199610000-00006 · Cited by 26
Trends in Hospital Admissions Among Children Aged 0–19 Years with Type I Diabetes in The Netherlands
Hirasing, R. A., Reeser, H. M., de Groot, R. R. M., Ruwaard, D., van Buuren, S., & Verloove-Vanhorick, S. P. (1996) · Diabetes Care · doi:10.2337/diacare.19.5.431 · Cited by 26
Outpatient Management of Diabetic Ketoacidosis
BONADIO, W. A., Gutzeit, M. F., Losek, J. D., & Smith, D. S. (1988) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1988.02150040102029 · Cited by 23
Recovery from Symptomatic Brain Swelling In Diabetic Ketoacidosis
Shabbir, N., Oberfield, S. E., Corrales, R., Kairam, R., & Levine, L. S. (1992) · Clinical Pediatrics · doi:10.1177/000992289203100914 · Cited by 19
Hoffman, W. H., Casanova, M. F., Bauza, J. A., Passmore, G. G., & Sekul, E. A. (1999) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(99)00042-2 · Cited by 10
Cited by
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Care of Children and Adolescents With Type 1 Diabetes
Silverstein, J., Klingensmith, G., Copeland, K., Plotnick, L., Kaufman, F., Laffel, L., Deeb, L., Grey, M., Anderson, B., Holzmeister, L. A., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.186 · Cited by 1,312
Wolfsdorf, J. I., Glaser, N., Agus, M., Fritsch, M., Hanas, R., Rewers, A., Sperling, M. A., & Codner, E. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12701 · Cited by 710
Self-citationDefinition, epidemiology and classification of diabetes in children and adolescents
Craig, M. E., Hattersley, A., & Donaghue, K. C. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00568.x · Cited by 461
Genetics of the HLA Region in the Prediction of Type 1 Diabetes
Noble, J. A., & Valdes, A. M. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0223-x · Cited by 460
Metadata
- Authors
- Dunger, D. B., Sperling, M. A., Acerini, C. L., Bohn, D. J., Daneman, D., Danne, T. P. A., Glaser, N. S., Hanas, R., Hintz, R. L., Levitsky, L. L., Savage, M. O., Tasker, R. C., & Wolfsdorf, J. I.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2004-02-01
- Volume
- 113
- Issue
- 2
- Pages
- e133-e140
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2118872672
- Cited by
- 296
- References
- 82
- FWCI
- 10.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.